Cargando…

Challenging T > MIC Using Meropenem vs. Escherichia coli and Pseudomonas aeruginosa

Objective: For meropenem 40%T > MIC is associated with optimal killing of P. aeruginosa and E. coli. However, it is unknown how the distribution of %T > MIC through a treatment day impacts the antimicrobial effect in vitro. Therefore, we investigated the in vitro antibiotic activity of meropen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nussbaumer-Pröll, A., Eberl, S., Kurdina, E., Schmidt, L., Zeitlinger, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010652/ https://www.ncbi.nlm.nih.gov/pubmed/35431957 http://dx.doi.org/10.3389/fphar.2022.840692

Ejemplares similares

Use of Supplemented or Human Material to Simulate PD Behavior of Antibiotics at the Target Site In Vitro
por: Nussbaumer-Pröll, Alina, et al.
Publicado: (2020)

Ecthyma Gangrenosum: Escherichia coli or Pseudomonas aeruginosa?
por: Abbas, Mohamed, et al.
Publicado: (2017)

Morphological and Bactericidal Effects of Amikacin, Meropenem and Imipenem on Pseudomonas aeruginosa
por: Moghoofei, Mohsen, et al.
Publicado: (2015)

Proteomic analysis of ceftazidime and meropenem-exposed Pseudomonas aeruginosa ATCC 9027
por: Ngo, Hong Loan, et al.
Publicado: (2023)

Reproducibility of Ceftolozane/Tazobactam MIC Results for Enterobacteriaceae and Pseudomonas aeruginosa Using MicroScan Dried Gram-negative MIC Panels
por: Harrington, Amanda, et al.
Publicado: (2017)

Reproducibility of Ceftazidime/Avibactam MIC Results for Enterobacteriaceae and Pseudomonas aeruginosa Using MicroScan Dried Gram Negative MIC Panels
por: Humphries, Romney, et al.
Publicado: (2017)

Impact of thrombocytes, on bacterial growth and antimicrobial activity of selected antibiotics
por: Nussbaumer-Pröll, Alina Karoline, et al.
Publicado: (2019)

Comparison of Antimycotic Activity of Originator and Generics of Voriconazole and Anidulafungin against Clinical Isolates of Candida albicans and Candida glabrata
por: Nussbaumer-Pröll, Alina Karoline, et al.
Publicado: (2022)

2131. Multicenter Evaluation of Meropenem/Vaborbactam MIC Results for Enterobacteriaceae Using MicroScan Dried Gram-Negative MIC Panels
por: Garner, Omai, et al.
Publicado: (2019)

Biomolecular Mechanisms of Pseudomonas aeruginosa and Escherichia coli Biofilm Formation
por: Laverty, Garry, et al.
Publicado: (2014)

The behaviour of Escherichia coli and Pseudomonas aeruginosa in bottled mineral water
por: Schalli, Michael, et al.
Publicado: (2023)

C/MIC > 4: A Potential Instrument to Predict the Efficacy of Meropenem
por: Zhao, Yichang, et al.
Publicado: (2022)

Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization
por: Cojutti, Pier Giorgio, et al.
Publicado: (2021)

Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
por: Dahdouh, E., et al.
Publicado: (2014)

Molecular Epidemiology and Mechanisms of High-Level Resistance to Meropenem and Imipenem in Pseudomonas aeruginosa
por: Hassuna, Noha Anwar, et al.
Publicado: (2020)

Sub-MIC of antibiotics induced biofilm formation of Pseudomonas aeruginosa in the presence of chlorhexidine
por: Aka, Safaa T., et al.
Publicado: (2015)

Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa
por: Kussmann, Manuel, et al.
Publicado: (2018)

521. Comparative In Vitro Activity of Meropenem/Vaborbactam and Meropenem Against a Collection of Real-World Clinical Isolates of Pseudomonas aeruginosa
por: Patel, Twisha S, et al.
Publicado: (2019)

Impact of erythrocytes on bacterial growth and antimicrobial activity of selected antibiotics
por: Nussbaumer-Pröll, Alina Karoline, et al.
Publicado: (2019)

Role of Fly Cleaning Behavior on Carriage of Escherichia coli and Pseudomonas aeruginosa
por: Jacques, B J, et al.
Publicado: (2017)

Antimicrobial Resistance of Escherichia coli and Pseudomonas aeruginosa from Companion Birds
por: Varriale, Lorena, et al.
Publicado: (2020)

Strategies to Tackle Antimicrobial Resistance: The Example of Escherichia coli and Pseudomonas aeruginosa
por: Antonelli, Giada, et al.
Publicado: (2021)

Candida albicans enhances meropenem tolerance of Pseudomonas aeruginosa in a dual-species biofilm
por: Alam, Farhana, et al.
Publicado: (2020)

Transcriptional profiling of Pseudomonas aeruginosa mature single- and dual-species biofilms in response to meropenem
por: Alam, Farhana, et al.
Publicado: (2023)

Effect of combined colistin and meropenem against meropenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa by checkerboard method: A cross sectional analytical study
por: Gunalan, Anitha, et al.
Publicado: (2021)

Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant Escherichia coli
por: Kim, Hye-Rim, et al.
Publicado: (2021)

Pseudomonas aeruginosa Promotes Escherichia coli Biofilm Formation in Nutrient-Limited Medium
por: Culotti, Alessandro, et al.
Publicado: (2014)

Human Target Attainment Probabilities for Delafloxacin against Escherichia coli and Pseudomonas aeruginosa
por: Hoover, Randall, et al.
Publicado: (2017)

Comparison of MICs in Escherichia coli isolates from human health surveillance with MICs obtained for the same isolates by broth microdilution
por: Suwono, Beneditta, et al.
Publicado: (2021)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

First Report of bla(OXA-677) with Enhanced Meropenem-Hydrolyzing Ability in Pseudomonas aeruginosa in China
por: Sun, Yue, et al.
Publicado: (2021)

Evaluating of the Effects of Sub-MIC Concentrations of Gentamicin on Biofilm Formation in Clinical Isolates of Pseudomonas aeruginosa
por: Yousefpour, Zahra, et al.
Publicado: (2021)

520. Development of Cefepime-taniborbactam MIC Antimicrobial Susceptibility Test (AST) for Enterobacterales and Pseudomonas aeruginosa on MicroScan Dried Gram-negative MIC Panels
por: Fernandez, Enrique J, et al.
Publicado: (2022)

Beneficial effect of Xuebijing against Pseudomonas aeruginosa infection in Caenorhabditis elegans
por: Zhang, Le, et al.
Publicado: (2022)

Escherichia coli BdcA controls biofilm dispersal in Pseudomonas aeruginosa and Rhizobium meliloti
por: Ma, Qun, et al.
Publicado: (2011)

Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Wang, Lei, et al.
Publicado: (2019)

Escherichia coli Nissle 1917 inhibits biofilm formation and mitigates virulence in Pseudomonas aeruginosa
por: Aljohani, Ahmad M., et al.
Publicado: (2023)

In Vivo Development of Aztreonam Resistance in Meropenem-Resistant Pseudomonas aeruginosa Owing to Overexpression of the bla(PDC-16)
por: Ding, Li, et al.
Publicado: (2023)

Successful treatment of multidrug-resistant Pseudomonas aeruginosa keratitis with meropenem eye drops — a case report
por: Elhardt, Carolin, et al.
Publicado: (2023)

Characterizing Blood-Stage Antimalarial Drug MIC Values In Vivo Using Reinfection Patterns
por: Watson, James, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g8semjbac8gevd1pf7trgc3acv